Cencora (STU:ABG) Cyclically Adjusted PS Ratio: (As of Aug. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:ABG Cencora Inc STU:ABG
70 GF Score
Price €276.20
GF Value €265.23
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Cencora Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cencora  (STU:ABG) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cencora Cyclically Adjusted PS Ratio Related Terms


Cencora Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Cencora's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Cyclically Adjusted PS Ratio Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.15 0.18 0.21 0.26

Cencora Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.26 0.27 0.25 0.22

STU:ABG vs CAH, MCK, HSIC: Cyclically Adjusted PS Ratio Comparison

For the Medical Distribution subindustry, Cencora's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Cyclically Adjusted PS Ratio falls into.


STU:ABG
70GF Score
Cencora Inc STU:ABG
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Cencora's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=379.322/333.9520*333.9520
=379.322

Current CPI (Jun. 2026) = 333.9520.

Cencora Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 147.496 241.428 204.022
201612 163.008 241.432 225.475
201703 157.005 243.801 215.061
201706 155.266 244.955 211.677
201709 148.304 246.819 200.659
201712 154.849 246.524 209.765
201803 149.699 249.554 200.327
201806 167.285 251.989 221.697
201809 170.638 252.439 225.737
201812 186.475 251.233 247.872
201903 180.360 254.202 236.944
201906 189.603 256.143 247.199
201909 193.725 256.759 251.967
201912 207.589 256.974 269.773
202003 207.247 258.115 268.138
202006 195.995 257.797 253.893
202009 204.864 260.280 262.851
202012 208.745 260.474 267.631
202103 199.163 264.877 251.101
202106 212.179 271.696 260.797
202109 237.524 274.310 289.168
202112 249.903 278.802 299.336
202203 247.224 287.504 287.165
202206 268.356 296.311 302.446
202209 294.301 296.808 331.131
202212 287.541 296.797 323.537
202303 290.170 301.836 321.045
202306 302.347 305.109 330.929
202309 317.536 307.789 344.528
202312 328.264 306.746 357.378
202403 312.865 312.332 334.522
202406 344.770 314.175 366.473
202409 359.607 315.301 380.879
202412 398.693 315.605 421.870
202503 357.749 319.799 373.582
202506 358.220 322.561 370.870
202509 365.193 324.800 375.483
202512 375.724 324.054 387.200
202603 346.897 330.213 350.825
202606 379.322 333.952 379.322

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cencora (STU:ABG) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be overvalued. The current stock price of €276.20 is trading 4.1% above its estimated GF Value™ of €265.23. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for STU:ABG:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €265.23 vs. price of €276.20 (4.1% above fair value)
  • GF Score™: 70/100 with 2 warning signs

No single metric tells the full story. See the STU:ABG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
70GF Score

Get the complete analysis for STU:ABG

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€276.20
Price
€265.23
GF Value